U.S. researchers identify new target for Alzheimer's disease: "WASHINGTON, Sept. 21 (Xinhua) -- Neurological researchers at Rush University Medical Center in Chicago have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.
Results from the study funded by the National Institutes of Health and the Alzheimer's Association will be published Wednesday in the Journal of Neuroscience."
No comments:
Post a Comment